CSCs are a small population of all cancer cells identified by using biomarkers such as cluster of differentiation (CD)44, CD166, NANOG, Oct4, ALDH1, and LGR5, and can effectively promote cancer onset, spread, and therapy resistance. This evidence concerns the gene ALCAM and cancer.